Lung Bioavailability With Continuous or Discontinuous Nebulization

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Status: Completed

Conditions: Healthy Subjects

Treatments: Device: AKITA

Study type: Interventional

Funder types: Other

Identifiers

NCT01913184

AKITA continuous

Details and patient eligibility

About

To compare the continuous and sicontinuous delivery of drug with AKITA.

Enrollment: 6 patients

Sex: Male

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• no lung disease
• no allergy

Exclusion criteria

• smoker

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

6 participants in 2 patient groups

Continuous nebulization

Active Comparator group

Description:

Continuous nebulization with AKITA

Treatment:

Device: AKITA

Discontinuous nebulization

Experimental group

Description:

Discontinuous nebulization with AKITA

Treatment:

Device: AKITA